Verition Fund Management »

Kyverna Therapeutics shares owned by Verition Fund Management

Quarter-by-quarter ownership of Kyverna Therapeutics (KYTX) shares owned by Verition Fund Management from 13F filings

Historical chart of Verition Fund Management investment in Kyverna Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Kyverna Therapeutics held by Verition Fund Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Kyverna Therapeutics by Verition Fund Management

Quarter filed Position value Share count Share price at filing
2024-12-31 $338k 90k 3.74
2024-09-30 $218k 45k 4.89

More positions owned by Verition Fund Management

NVIDIA Corporation (NVDA)
Ishares Tr Core S&p500 Etf (IVV)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Amazon (AMZN)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Ishares Tr Iboxx Hi Yd Etf (HYG)
Eli Lilly & Co. (LLY)
Ishares Tr Iboxx Inv Cp Etf (LQD)
Ishares Bitcoin Trust Etf Shs Ben Int (IBIT)
Warner Bros Discovery Com Ser A (WBD)
Norfolk Southern (NSC)
Cyberark Software SHS (CYBR)
Microsoft Corporation (MSFT)
Apple (AAPL)
Kraneshares Trust Csi Chi Internet Call Option (KWEB)

View all positions for Verition Fund Management

Top funds holding Kyverna Therapeutics

Vida Ventures Advisors
Gilead Sciences
Bain Capital Life Sciences Investors
Vanguard Group
Insight Holdings
Franklin Resources
Mbb Public Markets I
Catalio Capital Management
Millennium Management
BlackRock
Kera Capital Partners
Peapod Lane Capital
Geode Capital Management
Woodline Partners
Susquehanna International

View all funds holding Kyverna Therapeutics